Clinical trial

An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus…

NCT00289588 · Brooke Army Medical Center, U.S. Fed · Completed

Key facts

NCT number NCT00289588
Title An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers
Official title An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus Infection in Soldiers: a Controlled Trial
Lead sponsor Brooke Army Medical Center, U.S. Fed
Collaborators GlaxoSmithKline Industry Becton, Dickinson and Company
Status Completed
Study type Interventional
Conditions Community-Acquired MRSA Infections, Abscesses, Cellulitis, Folliculitis
Intervention type Drug
Interventions Mupirocin (drug)
Enrollment 3,000
Start date Jan 1, 2005
Completion Dec 1, 2005
First posted Feb 10, 2006
Last update posted Feb 16, 2006
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies